Genetically modified plants and bioengineered drugs
Start with the big picture
Plant genetic engineering uses methods such as Agrobacterium-mediated transfer, biolistic delivery, viral vectors, and CRISPR–Cas to alter gene expression. Applications include increasing metabolite yields, producing novel molecules, and improving resistance to pests or pathogens. Plant molecular farming uses plants or plant cells as biofactories, while hairy-root cultures, plastid engineering, and transient expression offer distinct production strategies. Making a product suitable for pharmaceutical use also requires downstream processing and quality checks, including identity, potency, glycosylation, and host-cell contaminants. Plant-made products are regulated as biologics, with biosafety, containment, and intellectual-property considerations also relevant to development.
What you'll learn
- Describe the purpose of genetic modification in pharmaceutical plants.
- Compare major gene-delivery technologies and plant production platforms.
- Explain how plant molecular farming supports biopharmaceutical production.
- Identify key downstream processing, quality-control, and regulatory considerations.
- Recognize biosafety and intellectual-property issues in plant-made products.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.